n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, October 6th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Lithium Corp. (LTUM)

FNNO Newsletters, AllPennyStocks, Breaking Bulls, OTCPicks, SmarTrend Newsletters, PickPennyStocks, Stockpalooza, Canadian Microcap Report, and Stockdigest Report reported earlier on Lithium Corp. (LTUM), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Lithium Corp. engages in the identification, acquisition, and exploration of metals and minerals with a concentration on lithium mineralization on properties in Nevada. The Company’s dedication is to the exploration for energy storage related resources throughout North America, looking to capitalize on opportunities within the increasing next generation energy storage markets. An exploration stage mining company listed on the OTCQB, Lithium is based in Elko, Nevada.

The Company maintains a strategic alliance with Altura Mining, which is a natural resource development company that recently announced it secured $110 million in project financing. Altura Mining is presently developing its 100 percent owned world-class Pilgangoora lithium pegmatite property in Western Australia.

Lithium’s flagship property is Fish Lake Valley. At Fish Lake Valley, the Company holds Placer claims that encompass approximately 7,800 acres. The Fish Lake Valley Property is in northern Esmeralda County in west-central Nevada.

Lithium also has its Hughes Property in Tonopah, Nevada. Lithco participated in the creation of Summa LLC, a private Nevada Limited Liability company that holds 88 fee-title patented lode claims that encompass roughly 1,191.3 acres of prospective mineral lands. Lithium signed a Joint Operating Agreement with the other participants to govern the conduct of Summa, and the development of the lands.

In north-western Nevada, Washoe County, Lithium has its San Emidio Project. It staked a block of claims in the San Emidio Valley during September 2011, and currently holds 1,600 acres. It also has its North Big Smokey lithium brine exploration property in Big Smokey Valley, Nye County, Nevada. The property is on federal lands. It comprises 44 association placer claims, most which are 80 acres.  In total the prospect is about 3400 acres. 

The Company has its BC Sugar Property in Shuswap, B.C. It has assembled a 19,816-acre (8,019 hectare) block of mineral claims in B.C. that is highly prospective for hosting commercially extractable deposits of flake graphite.

Lithium staked a block of claims in 2016 on the Buena Vista lithium-in-brine prospect in Pershing County, Nevada, totalling roughly 8,000 acres. The Company also announced in 2016 that it jointly staked with Idaho North Resources, Inc. (IDAH) a block of claims on the Gabbs Valley playa in Mineral County, Nevada totalling roughly 4,790 acres.

Lithium signed a Letter of Intent (LOI) this year on the Salt Wells lithium-in-brine prospect in Churchill County Nevada. With the agreement, Nevada Sunrise Gold Corp. (NVSGF) may earn a 100 percent interest in the property subject to a 2 percent Net Smelter Royalty (NSR) by making staged payments of cash and shares over the next two years.

This past June, Lithium announced that its permit application in support of the proposed trenching at its BC Sugar property was approved by the British Columbia Ministry of Energy and Mines. The Company is looking to ground truth frequency domain EM anomalies, which resulted from a geophysical survey conducted in the area in 2015.

In August, Lithium announced that it received preliminary assays from its BC Tantalum-Niobium project. Work has mainly centered on the Yeehaw prospect where, because of it being geologically alike and logistically superior, the knowledge that can be gained quite easily there can then be applied to the Michael prospect, making systematical exploration of that claim block much easier.

Rock sampling at Yeehaw has indicated that the Coryell Syenitic intrusive host rock is significantly "charged up" with values of Niobium (as high as 111.78 ppm), Tantalum (as high as 7.8 ppm), Lithium (as high as 48.4 ppm), and Cerium (as high as 324 ppm), among other notable elements, all substantially anomalous.

Lithium Corp. (LTUM), closed Friday's trading session at $0.08495, down 1.11%, on 16,788 volume with 14 trades. The average volume for the last 60 days is 139,538 and the stock's 52-week low/high is $0.046/$0.108.

Jackpot Digital, Inc. (JPOTF)

MarketWatch and InvestorsHub reported on Jackpot Digital, Inc. (JPOTF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Jackpot Digital, Inc. is a top electronic table games (ETG) manufacturer and mobile gaming provider for the cruise ship industry and regulated casino industry. The OTCQB-listed Company specializes in multiplayer gaming products. This includes poker and casino games. Jackpot Digital provides its iGaming products and services to the business to consumer (B2C) and business to business (B2B) market. Jackpot Digital is based in Vancouver, British Columbia. It formed in 1999, and was formerly Las Vegas From Home.com Entertainment, Inc.

In the Company’s B2C model, it generates revenue from wagering activities by players. In its B2B model, its platform partners own the brand and finance the marketing. Typically, Jackpot Digital shares the revenue produced from its games. The Company charges its platform partners for value added services such as software customization.

Furthermore, Jackpot Digital has a set of backend tools for operators to efficiently control and optimize their gaming business. The Company has its industry-leading PokerPro ETG (Electronic Table Games) system. Currently, PokerPro is in operation with cruise lines, poker rooms, and casinos worldwide.

In August 2015, Jackpot Digital bought the electronic table business unit from Multimedia Games. It consists of industry leading electronic poker tables under the PokerPro® brand name and a diverse multi-games table named ProCore™.

Regarding the social gaming market, Jackpot Digital has its Real Vegas Casino. This is a full-featured social casino on Facebook. The Company offers mobile gaming on cruise ships. Jackpot Digital’s plan is to bring its HTML5 mobile gaming technology from the Cruise Lines industry to the Hotel Industry.

The Company also has its Jackpot Blitz™. This is its proprietary next generation gaming platform, which it states will transform the poker Electronic Table Games (ETG) segment of the casino industry. Jackpot Blitz™, via its state-of-the-art technology, provides a first-rate player experience to go with premier operator efficiency, flexibility, and profitability. Jackpot Blitz™ features a modern design with a huge 84 inch 4K touchscreen. It can accommodate ten players simultaneously.

At the end of July 2017, Jackpot Digital announced that it entered into a Sales Agency and Support Services Agreement with R2 Gaming, Inc. With this agreement, R2 will serve as Jackpot Digital's exclusive sales and technical services partner throughout Canada for the Company's electronic table games (ETG) products. Additionally, R2 will continue to provide technical services for Jackpot's ETG clients in the Province of Ontario.

Jackpot Digital has also entered into a non-exclusive agreement to license and distribute its ETG products across Asia. The distributor is an established firm in the Asian gaming market. This firm has connections with manifold casino operating groups in Vietnam, Cambodia, Macau, as well as other Asian nations. With this agreement, they will market and license Jackpot Digital's ETGs to casinos, card rooms, and other gaming venues throughout Asia.

Jackpot Digital, Inc. (JPOTF), closed Friday's trading session at $0.046, up 2.22%, on 53,350 volume with 4 trades. The average volume for the last 60 days is 94,954 and the stock's 52-week low/high is $0.0035/$0.055.

Cocrystal Pharma, Inc. (COCP)

Microcapmillionaires, Promotion Stock Secrets, Wall Street Resources, and PennyStocks Forever reported on Cocrystal Pharma, Inc. (COCP) and we also report on the Company, here at the QualityStocks Daily Newsletter.

Cocrystal Pharma, Inc. develops novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company employs unique technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The design of these technologies, including its nucleoside chemistry expertise and market-focused approach to drug discovery, are to efficiently deliver small molecule therapeutics that are safe, effective, and convenient to administer. A biotechnology enterprise, Cocrystal Pharma has offices in Tucker, Georgia and Bothell, Washington.

Cocrystal Pharma has identified promising, preclinical stage antiviral compounds for unmet medical needs. These include hepatitis, influenza, and norovirus infections. Its proprietary technologies revolve around a structure-based drug discovery strategy teamed up with wide-ranging nucleoside experience. Using techniques called protein cocrystallization and X-ray crystallography, Cocrystal quickly identifies novel binding sites, identifies critical inhibitor-protein interactions, and optimizes the structure of the inhibitor in a highly rapid iterative fashion.

The Company is developing a series of compounds that are potent non-nucleoside and nucleoside inhibitors of hepatitis C NS5B RNA dependent RNA polymerase, a replication enzyme crucial to viral replication and is highly conserved between all hepatitis C genotypes. Therefore, inhibitors of this enzyme are likely to have multi- or pan-genotypic activity.

Cocrystal Pharma is also developing compounds that inhibit hepatitis C helicase and NS5A, two enzymes vital for viral replication. Also, the Company has identified a picomolar inhibitor of NS5A, another vital viral replication protein. Its compounds that target NS5B hepatitis C polymerase, NS5A, and NS3 helicase will undergo development as a combination treatment.

Recently, Cocrystal Pharma announced the successful completion and positive data from the Phase 1a/1b study for its lead broad spectrum compound, CC-31244, in healthy volunteers and in hepatitis C virus (HCV)-infected individuals. CC-31244 is a broad-spectrum, potent NS5B non-nucleoside inhibitor (NNI) of HCV replication with a high barrier to resistance.

There were no dose-limiting adverse events, study discontinuations because of adverse events, or serious adverse events reported. Mr. Gary L. Wilcox, Ph.D., Interim Chief Executive Officer of Cocrystal Pharma, said, "The successful completion of the Phase 1a/1b study represents a significant milestone for the Company. Given the absence of dose-limiting adverse effects in both healthy and HCV-infected subjects, and the significant antiviral effect observed in conjunction with the sustained antiviral activity post treatment, we are eager to advance CC-31244 into Phase 2 development in combination with other direct acting antivirals."

In September, Cocrystal Pharma announced that it entered into a research collaboration with HitGen, Ltd., a private biotechnology company and InterX, Inc., a private computer software company, to develop small molecule drug candidates against a number of undisclosed targets. Via the collaboration, Cocrystal, HitGen, and InterX scientists will apply HitGen's DNA-encoded library (DEL) technology platform and research capabilities in the design, synthesis, and screening of multiple proprietary DELs.

Cocrystal Pharma, Inc. (COCP), closed Friday's trading session at $0.245, down 7.89%, on 73,448 volume with 31 trades. The average volume for the last 60 days is 104,353 and the stock's 52-week low/high is $0.16/$0.518.

Mobiquity Technologies, Inc. (MOBQ)

PennyStocks24, PennyPickAlerts, Penny Stock Circle, 1-2-3 Stock Alerts, StockRockandRoll, PennyStockLocks, ResearchOTC, Stock Commander, SmallCapVoice, and StockMister reported earlier on Mobiquity Technologies, Inc. (MOBQ), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Mobiquity Technologies, Inc. operates a national location-based mobile advertising network. This network has developed a consumer-focused proximity network. Mobiquity Networks is a wholly-owned subsidiary of Mobiquity Technologies. Mobiquity Networks is the largest network of retail mall-based mobile advertising beacons in America. Mobiquity Networks is a next generation mobile location data intelligence and marketing company. Mobiquity Technologies is based in Garden City, New York.

Mobiquity Networks provides precise, unique, at-scale location based data and insights on consumers' real world behavior and trends. This is for use in marketing and research.

Mobiquity Technologies has exclusive agreements in hundreds of premier U.S. shopping malls. Its integrated group of unique location-based mobile advertising technologies enables retail and entertainment brands to execute personalized and contextually relevant experiences. This boosts brand awareness and incremental revenue.

Mobiquity Technologies is continuing to work to expand its location-based mobile advertising solutions to create "smart malls" in retail destinations throughout the U.S. employing Bluetooth-enabled iBeacon technology. By way of its subsidiaries, the Company provides brand marketing, advanced integrated marketing platforms, mobile marketing, social networks, Website development, and digital media solutions. It provides brand analysis and development, Website analysis and development, database analysis and building, and integrated marketing campaigns using direct mail, email marketing, mobile marketing, promotional products, and other mediums.

Furthermore, Mobiquity Technologies provides a proprietary Web development platform and delivers a content management system that puts content control back into the clients’ hands. The Company also provides hyper-local mobile marketing solutions. This includes a location-based marketing tool, which delivers digital content to Bluetooth or Wi-Fi enabled devices.

In June 2017, Mobiquity Networks announced the launch of the Passage Platform. This is its newly enhanced mobile device location platform. The new Passage Platform provides a significant leap ahead in the way marketers will be able to optimize active campaigns by measuring visits in real time.

This platform provides contextual and actionable insights. It enables marketers to more deeply engage with their most valuable consumers.

The Passage Platform provides a direct connection and deep understanding of consumers’ visitation behavior and engagement. The next generation business intelligence will enable store owners to enhance the in-store experiences and marketers their advertising strategy to increase visits.

In July of this year, Mobiquity Networks announced a new member to its team, Mr. Yuan Zhao. Mr. Zhao has a first-rate background in computer and data sciences. He joins the Mobiquity Networks development team as lead data scientist.

Mr. Zhao’s main goal will be enhancing Mobiquity’s Passage Platform with analytics and machine learning applications to further enrich data for customers. He comes to the Company from the IBM Watson Research Center, where he specialized in Geo-spatial Data and Audience Insights.

Mobiquity Technologies, Inc. (MOBQ), closed Friday's trading session at $0.05805, up 7.50%, on 8,729 volume with 2 trades. The average volume for the last 60 days is 33,339 and the stock's 52-week low/high is $0.009/$0.16.

Purebase Corp. (PUBC)

MarketWatch reported earlier on Purebase Corp. (PUBC), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Purebase Corp. concentrates on delivering high quality organic mineral products for the agricultural sector. A diversified, natural, and industrial mineral resource enterprise, the OTCQB-listed Company focuses on the acquisition, development, mining, and marketing of industrial and natural mineral properties in California, Nevada, and the rest of the U.S. as its main priority. Purebase has its corporate headquarters in Ione, California.

Concerning its facilities and properties, Purebase’s emphasis is on the commercialization of its three green mining properties. The Company owns two pozzolan projects, one in Northern California, and the other in Southern California. These serve the areas’ primary markets for the agricultural and construction sectors. Purebase’s potassium-sulfur project is in south-central Nevada close to the Company’s central valley agricultural market.

Regarding the agriculture industry, Purebase provides soil amendment and fertilizer solutions that are of major benefit to large commercial farming operations and retail consumer markets. Purebase Grow is a complete family of soil amendment products.

Grow products include Purebase Humate Advantage; Purebase Potassium & Sulfate Advantage; Purebase Soil Advantage; Purebase Shade Advantage; and Purebase Fulvic Advantage. The focus of these products is to provide a better, more natural way to grow, manage, and increase yield on the farm and deliver higher quality products to consumers’ tables.

Pertaining to the construction industry, Purebase provides a Supplementary Cementitious Material (SCM). This is an additive that may be used in cement for large infrastructure construction projects for government, commercial, as well as residential buildings. Purebase Build SCM significantly reduces greenhouse gas emissions and harmful particulate matter. Moreover, it reduces the overall cost of concrete, while increasing its strength.

Purebase has created Purebase Networks. This is an AgTech startup. Purebase Networks centers on combining Internet of Things (IoT) agricultural sensors, wireless networking, and cloud technologies to deliver the industry's first vertically integrated agricultural supply chain.

Purebase Networks will partner with Purebase Corp. to deliver proprietary, organic soil amendments for farmers. In addition, Purebase Networks will provide farmers with access to Purebase Networks' proprietary "Big Data" analytics. This is to provide more visibility into crop and soil performance.

This past July, Purebase announced that the California Department of Food and Agriculture (CDFA) issued a Notice of Certification to the Company for the organic certification of Purebase Soil Advantage within California. Purebase Soil Advantage is a proprietary blend of organic acids, organic matter, silicon dioxide, sulfur, iron, and a number of other micro nutrients. The design of it is to promote soil health and to provide plant nutrition.

Purebase Corp. (PUBC), closed Friday's trading session at $0.22438, even for the day. The average volume for the last 60 days is 4,201 and the stock's 52-week low/high is $0.02/$0.38.

graphic

The QualityStocks
Company Corner

graphic
graphic

Skinvisible, Inc. (SKVI)

The QualityStocks Daily Newsletter would like to spotlight Skinvisible, Inc. (SKVI). Today, Skinvisible, Inc. closed trading at $0.08, up 5.26%, on 146,981 volume with 26 trades. The stock’s average daily volume over the past 60 days is 97,665 and its 52-week low/high is $0.003/$0.33.

Skinvisible, Inc. (SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible's formulations to sell their own patented product and combat generic competitors.

A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of "gold standard" dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.

Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible's patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company's revenue stream.

Independent studies of Invisicare ® have shown the following benefits:

  • Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
  • Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
  • Unique formulations are non-drying and provide the ability to control the release of active ingredients.
  • Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin's natural exfoliation process.

Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company's business strategy.

Skinvisible's foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company's first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world's leading cannabis companies. As part of the company's overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible's cannabis products within their territory.

"We are excited about the results we are already seeing just with our hemp-derived CBD products," Howlett says. "Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare."

The Company's business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees. Disclaimer

Skinvisible, Inc. Blog

Skinvisible, Inc. News:

Skinvisible, Inc. (SKVI) is “One to Watch”

Skinvisible and Canopy Growth Enter License Agreement

Canopy Growth and Skinvisible Sign Definitive Agreement to Bring New Products to Market

EVIO, Inc. (EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO). Today, EVIO, Inc. closed trading at $0.90, off by 1.64%, on 27,017 volume with 22 trades. The stock’s average daily volume over the past 60 days is 1,595, and its 52-week low/high is $0.74/$5.45.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry. Disclaimer

EVIO, Inc. Company Blog

EVIO, Inc. News:

EVIO, Inc. (EVIO) is “One to Watch”

EVIO Labs to Provide Accredited Industrial Hemp Testing in Oregon

EVIO, Inc. (EVIO) Engages NetworkNewsWire for Corporate Communications Solutions

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.6099, up 13.51%, on 16,940 volume with 7 trades. The stock’s average daily volume over the past 60 days is 62,318 and its 52-week low/high is $0.20/$2.09.

ORHub, Inc. (OTC: ORHB), an advanced medical software provider focused on real-time digital delivery of case-based data analytics, today announces the appointment of Dr. Choll Kim, an industry-leading physician and instructor in the technological automation of surgical procedures, to its advisory board. As an internationally renowned expert in the field of computer-assisted, minimally invasive spine surgery, Dr. Kim has considerable insight into the intricate evolution of technology in the surgical sector, an invaluable resource that will strengthen ORHub's grasp in the marketplace.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub, Inc. Welcomes Internationally Recognized Spine Surgeon to its Advisory Board

ORHub, Inc. Completes over 2,000 Surgeries at Industry Leading Surgical Institution

ORHub, Inc. Completing 2-Year Financial Audit for Advancement to the OTCQB Market

Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF)

The QualityStocks Daily Newsletter would like to spotlight Blue Moon Zinc Corp. (BMOOF). Today, Blue Moon Zinc Corp. closed trading at $0.069, up 4.55%, on 27,500 volume with 5 trades. The stock’s average daily volume over the past 60 days is 18,088 and its 52-week low/high is $0.0074/$0.087.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the online availability of its interview with Blue Moon Zinc Corp. (TSX VENTURE: MOON) (OTC: BMOOF), a mineral exploration company focused on developing its advanced-stage, wholly owned Blue Moon zinc project in central California. The interview can be heard at http://NNW.fm/BMOOF-Oct-2017

Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF), a mineral exploration company, is focused on developing its advanced-stage, wholly owned Blue Moon zinc project in central California. The project sits within Mariposa County, an area of active mines and exploration projects since it was part of the California gold rush era. Blue Moon's 525 acres of mineral rights are assigned to patented and unpatented claims accessible by a gravel road off a nearby highway with main utility lines nearby.

The Blue Moon deposit is one of many located in the Foothills Massive Sulphide Belt in the Sierra Nevada Mountains of California. The property has a long history of exploration and saw small-scale mining during World War II. The current project, to be mined by underground methods, contains an estimated 3.70 million tons with a grade of 8.33% zinc equivalent for approximately 377 million pounds of zinc in the indicated category and another 4.09 million tons with a grade of 7.84% zinc equivalence for approximately 395 pounds of zinc in the inferred category. Significant bi-products of copper, silver and gold are also indicated. The deposit is open at depth and along strike with a high likelihood of expansion.

Current spot prices for zinc is approximately $1.40 per pound, which increases the potential returns of the Blue Moon project.

The historical database shows extensive plans to put the Blue Moon project into production, including several scoping and optimization studies. Past environmental work performed, along with an historical permit and reclamation plan approved for certain underground development, highlights past local county support for the project. These historical studies and permits are expected to help fast track the project's progress as they form an excellent base for the upcoming Preliminary Economic Assessment and later feasibility study.

Among the significant historical studies conducted is a 1998 metallurgical report that shows recovery rates of 95 percent for zinc and lead, 93 percent for copper, 65 percent for silver and 70 percent for gold (http://nnw.fm/U1ckE). The report indicates that simple processing methods will produce premium concentrates with easy separation of the economic minerals.

Blue Moon CEO Patrick McGrath, who has 20 years of experience in financing and executive roles in the junior mining public sector, is joined by a management team with successful track records in leading and participating in significant mineral discoveries with development-stage mining companies. The Blue Moon team also includes a member who permitted and built the Soledad mine in southern California in 2016 and a member who re-started the Mesquite mine in southern California. Local knowledge and know-how is key. The company also plans to engage a recognized third-party engineering firm to prepare a preliminary economic assessment report, expected for release in the first quarter of 2018, to demonstrate the economic viability of the Blue Moon mineral resources. Disclaimer

Blue Moon Zinc Corp. Blog

Blue Moon Zinc Corp. News:

NetworkNewsWire Releases Exclusive Audio Interview with Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF)

NetworkNewsWire Announces Publication Discussing the Favorable Outlook on Zinc

Blue Moon Announces Updated Mineral Resource Estimate

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0189, up 2.72%, on 1,282,589 volume with 72 trades. The stock’s average daily volume over the past 60 days is 2,641,253, and its 52-week low/high is $0.0077/$0.04.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Global Payout, Inc. (OTC PINK: GOHE), a client of NNW that provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The publication, titled, "Innovative Payment Solutions Blossom in the Expanding Cannabis Industry," discusses companies utilizing ground-breaking technology to provide payment solutions. To view the full publication, visit: https://www.networknewswire.com/innovative-payment-solutions-blossom-expanding-cannabis-industry/

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

NetworkNewsWire Announces Publication Highlighting Public Companies Creating Payment Solutions for the Cannabis Industry

Global Payout’s MoneyTrac Technology, Inc. Establishes a Revenue Sharing Joint Venture Partnership with BlazeNow Inc., an Emerging Cannabis Technology Company

NetworkNewsWire Announces Publication Discussing FinTech's Role in Disrupting Traditional Financial Services

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

BUYINS.NET
(OME) +32.83%

2.

Barchart
(SNCR) +32.00%

3.

ProTrader
(UMAX) +32.00%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251